个性化医疗、疾病预防与逆医疗法则：弊大于利？ - Suppr

Suppr

超能文献

Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?

作者信息

James Jack E

机构信息

Reykjavík University, Menntavegur 1, 101, Reykjavík, Iceland,

出版信息

Eur J Epidemiol. 2014 Jun;29(6):383-90. doi: 10.1007/s10654-014-9898-z. Epub 2014 Apr 12.

DOI:10.1007/s10654-014-9898-z

PMID:24729105

Abstract

摘要

相似文献

Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?

Eur J Epidemiol. 2014 Jun;29(6):383-90. doi: 10.1007/s10654-014-9898-z. Epub 2014 Apr 12.

Obesity Genes, Personalized Medicine, and Public Health Policy.

Curr Obes Rep. 2015 Sep;4(3):319-23. doi: 10.1007/s13679-015-0163-x.

Resetting priorities in precision medicine: the role of social prescribing.

J R Soc Med. 2020 Aug;113(8):310-313. doi: 10.1177/0141076820910325.

Genomics for disease treatment and prevention.

Psychiatr Clin North Am. 2011 Mar;34(1):147-66. doi: 10.1016/j.psc.2010.11.005. Epub 2010 Dec 22.

Personalised medicine: a critique on the future of health care.

J Bioeth Inq. 2013 Jun;10(2):197-203. doi: 10.1007/s11673-013-9429-8. Epub 2013 Mar 21.

Precision Medicine: From Science To Value.

Health Aff (Millwood). 2018 May;37(5):694-701. doi: 10.1377/hlthaff.2017.1624.

Personalized medicine: are we there yet?

J Cardiovasc Transl Res. 2008 Mar;1(1):3-4. doi: 10.1007/s12265-008-9016-2. Epub 2008 Mar 25.

Equity and Value in 'Precision Medicine'.

New Bioeth. 2017 Apr;23(1):87-94. doi: 10.1080/20502877.2017.1314891.

Precision medicine needs an equity agenda.

Nat Med. 2021 May;27(5):737. doi: 10.1038/s41591-021-01373-y.

The Promise and the Hype of 'Personalised Medicine'.

New Bioeth. 2017 Apr;23(1):13-20. doi: 10.1080/20502877.2017.1314886.

引用本文的文献

Managing the moral expansion of medicine.

BMC Med Ethics. 2022 Sep 22;23(1):97. doi: 10.1186/s12910-022-00836-2.

Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study.

BMC Endocr Disord. 2021 Oct 22;21(1):211. doi: 10.1186/s12902-021-00878-4.

Risk prediction model of gestational diabetes mellitus based on nomogram in a Chinese population cohort study.

Sci Rep. 2020 Dec 4;10(1):21223. doi: 10.1038/s41598-020-78164-x.

Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis.

BMC Med. 2020 Oct 23;18(1):282. doi: 10.1186/s12916-020-01753-0.

Resetting priorities in precision medicine: the role of social prescribing.

J R Soc Med. 2020 Aug;113(8):310-313. doi: 10.1177/0141076820910325.

Contributions of the UK biobank high impact papers in the era of precision medicine.

Eur J Epidemiol. 2020 Jan;35(1):5-10. doi: 10.1007/s10654-020-00606-7. Epub 2020 Jan 28.

The Limits of Empowerment: How to Reframe the Role of mHealth Tools in the Healthcare Ecosystem.

Sci Eng Ethics. 2020 Jun;26(3):1159-1183. doi: 10.1007/s11948-019-00115-1. Epub 2019 Jun 6.

Plastic diagnostics: The remaking of disease and evidence in personalized medicine.

Soc Sci Med. 2022 Jul;304:112318. doi: 10.1016/j.socscimed.2019.05.023. Epub 2019 May 18.

Molecular and genomic sciences in health: apply the established rules of evidence.

Int J Public Health. 2016 May;61(4):405-7. doi: 10.1007/s00038-015-0755-y. Epub 2015 Oct 26.

The commercialization of university-based research: Balancing risks and benefits.

BMC Med Ethics. 2015 Oct 14;16(1):70. doi: 10.1186/s12910-015-0064-2.

本文引用的文献

Essential elements of personalized medicine.

Urol Oncol. 2014 Feb;32(2):193-7. doi: 10.1016/j.urolonc.2013.09.002. Epub 2013 Dec 8.

Direct-to-consumer genomic testing offers little clinical utility but appears to cause minimal harm.

N C Med J. 2013 Nov-Dec;74(6):494-8.

An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.

Expert Opin Pharmacother. 2014 Feb;15(2):153-7. doi: 10.1517/14656566.2014.853039. Epub 2013 Nov 11.

Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review.

Bone. 2014 Jan;58:126-35. doi: 10.1016/j.bone.2013.09.023. Epub 2013 Oct 9.

Genetic screening for the risk of type 2 diabetes: worthless or valuable?

Diabetes Care. 2013 Aug;36 Suppl 2(Suppl 2):S120-6. doi: 10.2337/dcS13-2009.

Implications of genome-wide association studies in cancer therapeutics.

Br J Clin Pharmacol. 2013 Sep;76(3):370-80. doi: 10.1111/bcp.12166.

Harm, hype and evidence: ELSI research and policy guidance.

Genome Med. 2013 Mar 26;5(3):21. doi: 10.1186/gm425. eCollection 2013.

Why calls for more routine carotid stenting are currently inappropriate: an international, multispecialty, expert review and position statement.

Stroke. 2013 Apr;44(4):1186-90. doi: 10.1161/STROKEAHA.111.000261. Epub 2013 Mar 19.

In mildly symptomatic patients, should an invasive strategy with catheterization and revascularization be routinely undertaken?: in mildly symptomatic patients, an invasive strategy with catheterization and revascularization should not be routinely undertaken.

Circ Cardiovasc Interv. 2013 Feb;6(1):114-21; discussion 121. doi: 10.1161/CIRCINTERVENTIONS.112.973438.

How can polygenic inheritance be used in population screening for common diseases?

Genet Med. 2013 Jun;15(6):437-43. doi: 10.1038/gim.2012.182. Epub 2013 Feb 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验